Considering the potential pituitary tumor growth concern, a careful monitoring of ACTH levels and a pituitary magnetic resonance imaging every 6–12 months after initiating treatment, and thereafter every few years, are suggested [2]. This evidence concerns the gene POMC and pituitary tumor.